Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
- PMID: 25867461
- DOI: 10.1016/j.jneuroim.2015.02.004
Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
Abstract
Recent investigations support that an anti-aging protein, namely Klotho, protects neurons against the oxidative stress and demyelination. We evaluated the protein concentration of Klotho and total anti-oxidant capacity (TAC) in the cerebrospinal fluid (CSF) of patients with relapsing-remitting multiple sclerosis (RRMS). Klotho concentration and TAC were significantly lower in patients as compared to controls. Klotho values showed a significant negative correlation with expanded disability status scale (EDSS). Moreover, a significantly positive correlation between TAC levels and Klotho concentrations was detected. Klotho may play an important role in the pathogenesis of MS, at least in part, through the regulation of redox system.
Keywords: FRAP assay; Klotho; Multiple sclerosis; Redox system.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.Neurosci Lett. 2004 Jun 3;363(1):14-7. doi: 10.1016/j.neulet.2004.03.039. Neurosci Lett. 2004. PMID: 15157986
-
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.Mult Scler. 2012 Aug;18(8):1092-8. doi: 10.1177/1352458511433306. Epub 2012 Jun 13. Mult Scler. 2012. PMID: 22695538
-
Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome.Neurol Res. 2011 May;33(4):415-20. doi: 10.1179/016164110X12816242542535. Neurol Res. 2011. PMID: 21535941
-
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.Vojnosanit Pregl. 2012 Feb;69(2):151-6. Vojnosanit Pregl. 2012. PMID: 22500369
-
Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.J Neuroimmunol. 2012 Jan 18;242(1-2):26-32. doi: 10.1016/j.jneuroim.2011.08.013. Epub 2011 Dec 15. J Neuroimmunol. 2012. PMID: 22177943
Cited by
-
Oxidative Stress Markers in Multiple Sclerosis.Int J Mol Sci. 2024 Jun 7;25(12):6289. doi: 10.3390/ijms25126289. Int J Mol Sci. 2024. PMID: 38927996 Free PMC article. Review.
-
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.J Mol Neurosci. 2015 Oct;57(2):185-96. doi: 10.1007/s12031-015-0598-2. Epub 2015 Jun 12. J Mol Neurosci. 2015. PMID: 26067431
-
Klotho, the Key to Healthy Brain Aging?Brain Plast. 2018 Aug 10;3(2):183-194. doi: 10.3233/BPL-170057. Brain Plast. 2018. PMID: 30151342 Free PMC article. Review.
-
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial.Neural Regen Res. 2023 Dec;18(12):2599-2605. doi: 10.4103/1673-5374.373671. Neural Regen Res. 2023. PMID: 37449595 Free PMC article. Review.
-
In search of alternatively spliced alpha-Klotho Kl1 protein in mouse brain.FASEB Bioadv. 2021 May 19;3(7):531-540. doi: 10.1096/fba.2020-00066. eCollection 2021 Jul. FASEB Bioadv. 2021. PMID: 34258522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous